Eli Lilly Acquires Kilonia Therapeutics for $7 Billion
Eli Lilly and Company has announced its agreement to acquire Kilonia Therapeutics, a company specializing in gene delivery technologies, in a deal valued at $7 billion. This move aims to enhance Eli Lilly's capabilities in the field of genetic therapies.